Zhongchao Announces 1-for-8 Share Consolidation to Maintain Nasdaq Listing

An announcement from Zhongchao ( (ZCMD) ) is now available.

Zhongchao Inc., a healthcare-focused internet technology firm listed on Nasdaq under the symbol ZCMD, consolidates results from its PRC operating entities that run the MDMOOC professional education platform, tumor and rare disease patient management services, an internet hospital, and the Sunshine Health Forums for the general public. The company targets medical professionals and patients dealing with cancer and other serious diseases, positioning itself in China’s fast-growing online healthcare and medical education market.

On February 10, 2026, Zhongchao’s shareholders and board approved a share consolidation framework, and specifically a 1-for-8 consolidation of both Class A and Class B ordinary shares, to take effect on March 2, 2026. Announced on February 26, 2026, this move will reduce the number of outstanding Class A shares from about 25.75 million to roughly 3.22 million and Class B shares from about 5.0 million to about 625,000, with fractional shares rounded up, and is aimed at regaining compliance with Nasdaq’s minimum bid price rule while leaving shareholders’ proportional ownership largely unchanged.

Beginning at the open of trading on March 2, 2026, Zhongchao’s Class A shares will trade on a post-consolidation basis on the Nasdaq Capital Market under the same ticker ZCMD but with a new CUSIP, following the effectiveness of an amended and restated memorandum of association. The uniform treatment of all shareholders and the lack of dilution or change in percentage ownership suggest the primary impact is on share price mechanics and listing compliance rather than on underlying operations, though it may influence market perception of the company’s stability and capital market strategy.

Spark’s Take on ZCMD Stock

According to Spark, TipRanks’ AI Analyst, ZCMD is a Neutral.

Zhongchao’s overall stock score is low primarily due to significant financial struggles, including negative cash flows and net losses. Technical analysis indicates a bearish trend, further weighing on the stock. Valuation metrics are also unfavorable, with a negative P/E ratio and no dividend yield, suggesting limited investor appeal at present.

To see Spark’s full report on ZCMD stock, click here.

More about Zhongchao

Zhongchao Inc. is a Cayman Islands-incorporated, platform-based internet technology company focused on healthcare services for oncology and other major diseases, primarily in China. Through PRC operating entities, it provides online medical information, professional training via its MDMOOC platform, patient management for tumors and rare diseases, internet hospital services, and a consumer-facing health information platform.

Average Trading Volume: 1,663,752

Technical Sentiment Signal: Sell

Current Market Cap: $5.81M

For detailed information about ZCMD stock, go to TipRanks’ Stock Analysis page.